Maelstrom Research Staging | SSSIS_Vaccine_immunity_residents_18_month_post_second

SSSIS_Vaccine_immunity_residents_18_month_post_second_dose

Networks -

Variables -

Associated study SSSIS Contingency Table

Population

SSSIS - Vaccine immunity residents

The population is composed of residents of LTCF who have agreed to participate in the immunity study in Edmonton, Alberta.

Selection Criteria

Newborns

Twins

Countries

Canada

Territory

Edmonton

Ethnic Origin

Health Status

Recruitment

Sources of recruitment

Specific population

Specific Population

Other specific population : LTCF Residents

Supplementary Information

An infographic and a letter of invitation was circulated to three professional membership bodies for continuing care providers in Alberta, namely Alberta Continuing Care Association, Alberta Seniors Communities and Housing Association, and the Christian Health Associa-tion of Alberta, asking for the information to be distrib-uted to their members to solicit interest in the study.

Number of Participants

Number of Participants: 250
Number of Participants with Biological Samples: 250
Supplementary Information about selection criteria

More info

Data Collection Event

SSSIS - Vaccine immunity residents - 18-month post second dose

Information about dates of COVID-19 tests and results, hospitalization, ICU admission, COVID-19 related death, dates of vaccination, reaction to the vaccination, accommodation and shared space for eating was collected. Blood samples were collected for COVID-19 antibody tests.

More info

Collected Dataset / SSSIS_Vaccine_immunity_residents_18_month_post_second_dose

SSSIS_Vaccine_immunity_residents_18_month_post_second_dose

Population

SSSIS - Vaccine immunity residents

Data Collection Event

SSSIS - Vaccine immunity residents - 18-month post second dose

Files

Variables Classifications